The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 23 March 2004, www.theannals.com, DOI 10.1345/aph.1D396.
 The Annals of Pharmacotherapy: Vol. 38, No. 5, pp. 839-844. DOI 10.1345/aph.1D396
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anthony, K. K
Right arrow Articles by Mauro, V. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anthony, K. K
Right arrow Articles by Mauro, V. F

THERAPEUTIC CONTROVERSIES

Rate Versus Rhythm Control in Atrial Fibrillation

Korin K Anthony, BSPharm Sci

PharmD Student, University of Toledo, Toledo, OH

Vincent F Mauro, PharmD FCCP

Associate Professor of Clinical Pharmacy, College of Pharmacy, University of Toledo; Adjunct Associate Professor of Medicine, Department of Medicine, Medical College of Ohio, Toledo

Reprints: Korin K Anthony BSPharm Sci, University of Toledo, 16751 US 127, Ohio City, OH 45874-9227, korinrph{at}hotmail.com

OBJECTIVE: To determine whether rate control is a viable initial treatment approach in persistent atrial fibrillation (AF) through the evaluation of recently completed trials comparing rate and rhythm control.

DATA SOURCES: Biomedical literature was obtained through MEDLINE (1966–December 2003) and the Iowa database.

STUDY SELECTION AND DATA EXTRACTION: Articles identified from the biomedical literature search were reviewed and included if deemed relevant.

DATA SYNTHESIS: Currently available data suggest that rate control is not inferior to rhythm control in patients with persistent AF with respect to mortality. Rate control also reduces hospitalizations and the occurrence of proarrhythmias. No significant difference was observed between treatments with respect to thromboembolism and strokes.

CONCLUSIONS: Due to the increased incidence of hospitalizations and antiarrhythmic adverse effects associated with rhythm control, rate control is a reasonable first-line strategy in the treatment of recurrent AF, especially in elderly patients who are asymptomatic or mildly symptomatic. Further studies are needed to clearly define the role of rate control in younger patients.

Key Words: atrial fibrillation, rate, rhythm

Published Online, March 23, 2004. www.theannals.com, DOI 10.1345/aph.1D396

THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-04-017-H01




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.